empagliflozin
…ple with T2DM and established CVD to receive either the SGLT2i, empagliflozin, or placebo.5 To be eligible for this study, people had to meet…
3articles mentioning drugs
5drug mentions
1distinct drugs extracted
0%of mentions human-reviewed
Active filtersEntity: ertugliflozin ×
ertugliflozin
This drug is selected. Its supporting articles are shown below.
Articles mentioning ertugliflozin
3 articles · page 1 of 1CanagliflozinDapagliflozinfinerenoneEmpagliflozinsemaglutideertugliflozinGLP-1RAMRAMineralocorticoid Receptor AntagonistsCardio-Renal-Metabolic syndrome+3 more
… kidney disease progression by 24% [HR 0.76; 95% CI 0.67–0.87]. Canagliflozin reduced the composite renal outcome [HR 0.66; 95% CI 0.53–0.81]…